Shang Cao1, Zheng Zhu2, Jinyi Zhou2, Wei Li1, Yunqiu Dong3, Yun Qian3, Pingmin Wei4, Ming Wu5,6. 1. Department of Epidemiology and Health Statistics, Southeast University, , Dingjiaqiao Road 87th, Nanjing 210009, Jiangsu, Nanjing, China. 2. Department of Chronic Disease Control, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China. 3. Department of Health Promotion and Chronic Non-Communicable Disease Control, Wuxi Center for Disease Control and Prevention, Wuxi, China. 4. Department of Epidemiology and Health Statistics, Southeast University, , Dingjiaqiao Road 87th, Nanjing 210009, Jiangsu, Nanjing, China. mpw1963@126.com. 5. Department of Epidemiology and Health Statistics, Southeast University, , Dingjiaqiao Road 87th, Nanjing 210009, Jiangsu, Nanjing, China. mingwu@seu.edu.cn. 6. Department of Chronic Disease Control, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China. mingwu@seu.edu.cn.
Abstract
PURPOSE: Breast cancer is more likely attributed to a combination of genetic variations and lifestyle factors. Both one-carbon metabolism and diet-related factors could interfere with the carcinogenesis of breast cancer (BC), but whether diet consumed underlie a specific metabolism pathway could influence the impact of genetic variants on breast cancer risk remains equivocal. METHODS: A case-control study of the Chinese female population (818 cases, 935 controls). 13 SNPs in eight one-carbon metabolism-related genes (MTHFD1, TYMS, MTRR, MAT2B, CDO1, FOLR1, UNG2, ADA) were performed. Diet was assessed by a validated food-frequency questionnaire. We examined the associations of the adherence to the Mediterranean dietary pattern (MDP) and single-nucleotide polymorphisms (SNPs) of one-carbon metabolism with breast cancer risk. We constructed an aggregate polygenic risk score (PRS) to test the additive effects of genetic variants and analyzed the gene-diet interactions. RESULTS: High adherence (highest quartile) to the MDP decreased the risk of breast cancer among post- but not premenopausal women, respectively (OR = 0.54, 95% CI = 0.38 to 0.78 and 0.90, 0.53 to 1.53). Neither of the polymorphisms or haplotypes was associated with breast cancer risk, irrespective of menopause. However, a high PRS (highest quartile) was associated with more than a doubling risk in both post- and premenopausal women, respectively (OR = 1.95, 95% CI = 1.32 to 2.87 and 2.09, 1.54 to 2.85). We found a gene-diet interaction with adherence to the MDP for aggregate PRS (P-interaction = 0.000) among postmenopausal women. When adherence to the MDP was low (< median), carries with high PRS (highest quartile) had higher BC risk (OR = 2.80, 95% CI = 1.55 to 5.07) than low PRS (lowest quartile), while adherence to the MDP was high (≥ median), the association disappeared (OR = 1.57, 95% CI = 0.92 to 2.66). CONCLUSION: High adherence to the MDP may counteract the genetic predisposition associated with one-carbon metabolism on breast cancer risk in postmenopausal women.
PURPOSE:Breast cancer is more likely attributed to a combination of genetic variations and lifestyle factors. Both one-carbon metabolism and diet-related factors could interfere with the carcinogenesis of breast cancer (BC), but whether diet consumed underlie a specific metabolism pathway could influence the impact of genetic variants on breast cancer risk remains equivocal. METHODS: A case-control study of the Chinese female population (818 cases, 935 controls). 13 SNPs in eight one-carbon metabolism-related genes (MTHFD1, TYMS, MTRR, MAT2B, CDO1, FOLR1, UNG2, ADA) were performed. Diet was assessed by a validated food-frequency questionnaire. We examined the associations of the adherence to the Mediterranean dietary pattern (MDP) and single-nucleotide polymorphisms (SNPs) of one-carbon metabolism with breast cancer risk. We constructed an aggregate polygenic risk score (PRS) to test the additive effects of genetic variants and analyzed the gene-diet interactions. RESULTS: High adherence (highest quartile) to the MDP decreased the risk of breast cancer among post- but not premenopausal women, respectively (OR = 0.54, 95% CI = 0.38 to 0.78 and 0.90, 0.53 to 1.53). Neither of the polymorphisms or haplotypes was associated with breast cancer risk, irrespective of menopause. However, a high PRS (highest quartile) was associated with more than a doubling risk in both post- and premenopausal women, respectively (OR = 1.95, 95% CI = 1.32 to 2.87 and 2.09, 1.54 to 2.85). We found a gene-diet interaction with adherence to the MDP for aggregate PRS (P-interaction = 0.000) among postmenopausal women. When adherence to the MDP was low (< median), carries with high PRS (highest quartile) had higher BC risk (OR = 2.80, 95% CI = 1.55 to 5.07) than low PRS (lowest quartile), while adherence to the MDP was high (≥ median), the association disappeared (OR = 1.57, 95% CI = 0.92 to 2.66). CONCLUSION: High adherence to the MDP may counteract the genetic predisposition associated with one-carbon metabolism on breast cancer risk in postmenopausal women.
Authors: Marian L Neuhouser; Aaron K Aragaki; Ross L Prentice; JoAnn E Manson; Rowan Chlebowski; Cara L Carty; Heather M Ochs-Balcom; Cynthia A Thomson; Bette J Caan; Lesley F Tinker; Rachel Peragallo Urrutia; Jennifer Knudtson; Garnet L Anderson Journal: JAMA Oncol Date: 2015-08 Impact factor: 31.777
Authors: A Antoniou; P D P Pharoah; S Narod; H A Risch; J E Eyfjord; J L Hopper; N Loman; H Olsson; O Johannsson; A Borg; B Pasini; P Radice; S Manoukian; D M Eccles; N Tang; E Olah; H Anton-Culver; E Warner; J Lubinski; J Gronwald; B Gorski; H Tulinius; S Thorlacius; H Eerola; H Nevanlinna; K Syrjäkoski; O-P Kallioniemi; D Thompson; C Evans; J Peto; F Lalloo; D G Evans; D F Easton Journal: Am J Hum Genet Date: 2003-04-03 Impact factor: 11.025
Authors: Yiwey Shieh; Donglei Hu; Lin Ma; Scott Huntsman; Charlotte C Gard; Jessica W T Leung; Jeffrey A Tice; Celine M Vachon; Steven R Cummings; Karla Kerlikowske; Elad Ziv Journal: Breast Cancer Res Treat Date: 2016-08-26 Impact factor: 4.872
Authors: Wanqing Wen; Xiao-Ou Shu; Xingyi Guo; Qiuyin Cai; Jirong Long; Manjeet K Bolla; Kyriaki Michailidou; Joe Dennis; Qin Wang; Yu-Tang Gao; Ying Zheng; Alison M Dunning; Montserrat García-Closas; Paul Brennan; Shou-Tung Chen; Ji-Yeob Choi; Mikael Hartman; Hidemi Ito; Artitaya Lophatananon; Keitaro Matsuo; Hui Miao; Kenneth Muir; Suleeporn Sangrajrang; Chen-Yang Shen; Soo H Teo; Chiu-Chen Tseng; Anna H Wu; Cheng Har Yip; Jacques Simard; Paul D P Pharoah; Per Hall; Daehee Kang; Yongbing Xiang; Douglas F Easton; Wei Zheng Journal: Breast Cancer Res Date: 2016-12-08 Impact factor: 6.466
Authors: Hannah R Brewer; Michael E Jones; Minouk J Schoemaker; Alan Ashworth; Anthony J Swerdlow Journal: Breast Cancer Res Treat Date: 2017-06-03 Impact factor: 4.872
Authors: D Torres; J Lorenzo Bermejo; M U Rashid; I Briceño; F Gil; A Beltran; V Ariza; U Hamann Journal: Sci Rep Date: 2017-07-05 Impact factor: 4.379
Authors: Ben Zhang; Xiao-Ou Shu; Ryan J Delahanty; Chenjie Zeng; Kyriaki Michailidou; Manjeet K Bolla; Qin Wang; Joe Dennis; Wanqing Wen; Jirong Long; Chun Li; Alison M Dunning; Jenny Chang-Claude; Mitul Shah; Barbara J Perkins; Kamila Czene; Hatef Darabi; Mikael Eriksson; Stig E Bojesen; Børge G Nordestgaard; Sune F Nielsen; Henrik Flyger; Diether Lambrechts; Patrick Neven; Hans Wildiers; Giuseppe Floris; Marjanka K Schmidt; Matti A Rookus; Katja van den Hurk; Wim L A M de Kort; Fergus J Couch; Janet E Olson; Emily Hallberg; Celine Vachon; Anja Rudolph; Petra Seibold; Dieter Flesch-Janys; Julian Peto; Isabel Dos-Santos-Silva; Olivia Fletcher; Nichola Johnson; Heli Nevanlinna; Taru A Muranen; Kristiina Aittomäki; Carl Blomqvist; Jingmei Li; Keith Humphreys; Judith Brand; Pascal Guénel; Thérèse Truong; Emilie Cordina-Duverger; Florence Menegaux; Barbara Burwinkel; Frederik Marme; Rongxi Yang; Harald Surowy; Javier Benitez; M Pilar Zamora; Jose I A Perez; Angela Cox; Simon S Cross; Malcolm W R Reed; Irene L Andrulis; Julia A Knight; Gord Glendon; Sandrine Tchatchou; Elinor J Sawyer; Ian Tomlinson; Michael J Kerin; Nicola Miller; Georgia Chenevix-Trench; Christopher A Haiman; Brian E Henderson; Fredrick Schumacher; Loic Le Marchand; Annika Lindblom; Sara Margolin; Maartje J Hooning; John W M Martens; Madeleine M A Tilanus-Linthorst; J Margriet Collée; John L Hopper; Melissa C Southey; Helen Tsimiklis; Carmel Apicella; Susan Slager; Amanda E Toland; Christine B Ambrosone; Drakoulis Yannoukakos; Graham G Giles; Roger L Milne; Catriona McLean; Peter A Fasching; Lothar Haeberle; Arif B Ekici; Matthias W Beckmann; Hermann Brenner; Aida Karina Dieffenbach; Volker Arndt; Christa Stegmaier; Anthony J Swerdlow; Alan Ashworth; Nick Orr; Michael Jones; Jonine Figueroa; Montserrat Garcia-Closas; Louise Brinton; Jolanta Lissowska; Martine Dumont; Robert Winqvist; Katri Pylkäs; Arja Jukkola-Vuorinen; Mervi Grip; Hiltrud Brauch; Thomas Brüning; Yon-Dschun Ko; Paolo Peterlongo; Siranoush Manoukian; Bernardo Bonanni; Paolo Radice; Natalia Bogdanova; Natalia Antonenkova; Thilo Dörk; Arto Mannermaa; Vesa Kataja; Veli-Matti Kosma; Jaana M Hartikainen; Peter Devilee; Caroline Seynaeve; Christi J Van Asperen; Anna Jakubowska; Jan Lubiński; Katarzyna Jaworska-Bieniek; Katarzyna Durda; Ute Hamann; Diana Torres; Rita K Schmutzler; Susan L Neuhausen; Hoda Anton-Culver; Vessela N Kristensen; Grethe I Grenaker Alnæs; Brandon L Pierce; Peter Kraft; Ulrike Peters; Sara Lindstrom; Daniela Seminara; Stephen Burgess; Habibul Ahsan; Alice S Whittemore; Esther M John; Marilie D Gammon; Kathleen E Malone; Daniel C Tessier; Daniel Vincent; Francois Bacot; Craig Luccarini; Caroline Baynes; Shahana Ahmed; Mel Maranian; Catherine S Healey; Anna González-Neira; Guillermo Pita; M Rosario Alonso; Nuria Álvarez; Daniel Herrero; Paul D P Pharoah; Jacques Simard; Per Hall; David J Hunter; Douglas F Easton; Wei Zheng Journal: J Natl Cancer Inst Date: 2015-08-20 Impact factor: 13.506
Authors: V Benetou; A Trichopoulou; P Orfanos; A Naska; P Lagiou; P Boffetta; D Trichopoulos Journal: Br J Cancer Date: 2008-07-08 Impact factor: 7.640
Authors: Antonia Trichopoulou; Miguel A Martínez-González; Tammy Yn Tong; Nita G Forouhi; Shweta Khandelwal; Dorairaj Prabhakaran; Dariush Mozaffarian; Michel de Lorgeril Journal: BMC Med Date: 2014-07-24 Impact factor: 8.775